このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Evolent Health 過去の業績
過去 基準チェック /06
Evolent Healthは28.1%の年平均成長率で業績を伸ばしているが、Healthcare Services業界はgrowingで8.3%毎年増加している。売上は成長しており、年平均22.1%の割合である。
主要情報
28.1%
収益成長率
33.2%
EPS成長率
| Healthcare Services 業 界の成長 | 1.7% |
| 収益成長率 | 22.1% |
| 株主資本利益率 | -9.0% |
| ネット・マージン | -6.5% |
| 前回の決算情報 | 31 Mar 2024 |
最近の業績更新
Recent updates
Evolent Health: Recent Pullback, A Buying Opportunity Or Not? (Rating Downgrade)
May 22These 4 Measures Indicate That Evolent Health (NYSE:EVH) Is Using Debt Reasonably Well
May 05
Evolent Health, Inc. (NYSE:EVH) Doing What It Can To Lift Shares
Apr 08Evolent Health (NYSE:EVH) Is Experiencing Growth In Returns On Capital
Mar 12Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt
Jan 17Many Still Looking Away From Evolent Health, Inc. (NYSE:EVH)
Dec 21Evolent Health (NYSE:EVH) Is Looking To Continue Growing Its Returns On Capital
Nov 30A First Evaluation On Evolent Health
Oct 04Does Evolent Health (NYSE:EVH) Have A Healthy Balance Sheet?
Sep 29There's Been No Shortage Of Growth Recently For Evolent Health's (NYSE:EVH) Returns On Capital
Sep 01An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 47% Undervalued
Aug 04Evolent Health: Business Economics Still Appealing, Reiterate Buy
Jul 19Cautious Investors Not Rewarding Evolent Health, Inc.'s (NYSE:EVH) Performance Completely
Jun 14Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt
May 30An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 34% Undervalued
May 02Evolent Health (NYSE:EVH) Shareholders Will Want The ROCE Trajectory To Continue
Apr 17Evolent Health GAAP EPS of $0.11 beats by $0.13, revenue of $382.4M beats by $9.47M
Feb 22Is Evolent Health (NYSE:EVH) A Risky Investment?
Feb 19Evolent Health: Strengthening Fundamentals, Investing At High Rates Of Return
Feb 15Is Evolent Health, Inc. (NYSE:EVH) Potentially Undervalued?
Feb 01Evolent Health (NYSE:EVH) Might Have The Makings Of A Multi-Bagger
Jan 14Evolent spikes as Humana partnership expands
Jan 12Is Evolent Health, Inc. (NYSE:EVH) Trading At A 49% Discount?
Dec 27Evolent Health offered $23.5M class action securities settlement
Sep 19Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher
Sep 18Evolent Health: Improving Financials, But There's More
Aug 31Is Evolent Health (NYSE:EVH) A Risky Investment?
Aug 05Evolent Health initiated at outperform at RBC on organic revenue growth opportunity
Jul 29収支内訳
収支内訳
Evolent Health の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 31 Mar 24 | 2,176 | -141 | 298 | 0 |
| 31 Dec 23 | 1,964 | -142 | 306 | 0 |
| 30 Sep 23 | 1,790 | -112 | 307 | 0 |
| 30 Jun 23 | 1,632 | -77 | 287 | 0 |
| 31 Mar 23 | 1,483 | -40 | 263 | 0 |
| 31 Dec 22 | 1,352 | -19 | 244 | 0 |
| 30 Sep 22 | 1,218 | -4 | 243 | 0 |
| 30 Jun 22 | 1,088 | -19 | 229 | 0 |
| 31 Mar 22 | 990 | -24 | 215 | 0 |
| 31 Dec 21 | 908 | -30 | 208 | 0 |
| 30 Sep 21 | 906 | -45 | 199 | 0 |
| 30 Jun 21 | 923 | -68 | 199 | 0 |
| 31 Mar 21 | 918 | -261 | 197 | 0 |
| 31 Dec 20 | 925 | -328 | 198 | 0 |
| 30 Sep 20 | 915 | -515 | 196 | 0 |
| 30 Jun 20 | 895 | -504 | 207 | 0 |
| 31 Mar 20 | 870 | -334 | 228 | 0 |
| 31 Dec 19 | 687 | -304 | 208 | 0 |
| 30 Sep 19 | 803 | -121 | 248 | 0 |
| 30 Jun 19 | 733 | -107 | 247 | 0 |
| 31 Mar 19 | 685 | -86 | 241 | 0 |
| 31 Dec 18 | 627 | -53 | 231 | 0 |
| 30 Sep 18 | 548 | -49 | 220 | 0 |
| 30 Jun 18 | 506 | -49 | 206 | 0 |
| 31 Mar 18 | 468 | -56 | 199 | 0 |
| 31 Dec 17 | 435 | -61 | 195 | 0 |
| 30 Sep 17 | 409 | -65 | 191 | 0 |
| 30 Jun 17 | 362 | -64 | 180 | 0 |
| 31 Mar 17 | 311 | -55 | 163 | 0 |
| 31 Dec 16 | 254 | -160 | 148 | 0 |
| 30 Sep 16 | 212 | -146 | 131 | 0 |
| 30 Jun 16 | 192 | -147 | 122 | 0 |
| 31 Mar 16 | 146 | 220 | 103 | 0 |
| 31 Dec 15 | 97 | 330 | 71 | 0 |
| 30 Sep 15 | 51 | 322 | 38 | 0 |
| 30 Jun 15 | 10 | 329 | 13 | 0 |
| 31 Mar 15 | 0 | -37 | -1 | 0 |
| 31 Dec 14 | 0 | -31 | 0 | 0 |
| 30 Sep 14 | 13 | -29 | 7 | 0 |
| 31 Dec 13 | 26 | 2 | 16 | 0 |
質の高い収益: EVHは現在利益が出ていません。
利益率の向上: EVHは現在利益が出ていません。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: EVHは利益を出していないが、過去 5 年間で年間28.1%の割合で損失を削減してきた。
成長の加速: EVHの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。
収益対業界: EVHは利益が出ていないため、過去 1 年間の収益成長をHealthcare Services業界 ( 8.6% ) と比較することは困難です。
株主資本利益率
高いROE: EVHは現在利益が出ていないため、自己資本利益率 ( -8.98% ) はマイナスです。